Vascularized organ bioprinting: From strategy to paradigm
Cell Proliferation · 2023-05 · 56 (5)
DOI: 10.1111/cpr.13453 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2023-03-16. Written by Heran Wang and 3 co-authors. Institution: State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China. Major MEDLINE topics: Tissue Engineering, Bioprinting. Cited 25 times so far (Crossref); 103 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, The Foundation of State Key Laboratory of Robotics, The National Key Research and Development Program of China.
Abstract (original language)
Over the past two decades, 3D bioprinting has become a popular research topic worldwide, as it is the most promising approach for manufacturing vascularized organs in vitro. However, transitioning from bioprinting of simple tissue models to real biomedical applications is still a challenge due to incomplete interdisciplinary theoretical knowledge and imperfect multi‐technology integration. This review examines the goals of vasculature manufacturing and proposes new strategic objectives in three stages. We then outline a bidirectional manufacturing strategy consisting of top‐down reconstruction (bioprinting) and bottom‐up regeneration (cellular behaviour). We also provide an in‐depth analysis of the four aspects of design, ink, printing and culture. Furthermore, we present the ‘construction‐comprehension cycle’ research paradigm and the ‘math‐model‐based batch insights generator’ research paradigm for the future, which may have the potential to revolutionize the biomedical field.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China.
- Institutes for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, China.
- University of Chinese Academy of Sciences, Beijing, China.
- State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
ORCID profiles: Heran Wang, Xin Liu, Qi Gu, Xiongfei Zheng
Funding
- National Natural Science Foundation of China
- The Foundation of State Key Laboratory of Robotics
- The National Key Research and Development Program of China
- The Research Equipment Development Program of CAS
- The Strategic Priority Research Program of CAS
- CAS Project for Young Scientists in Basic Research
Cite
APA
Wang, H., Liu, X., Gu, Q., & Zheng, X. (2023). Vascularized organ bioprinting: From strategy to paradigm. Cell Proliferation, 56(5). https://doi.org/10.1111/cpr.13453
Vancouver
Wang H, Liu X, Gu Q, Zheng X. Vascularized organ bioprinting: From strategy to paradigm. Cell Proliferation. 2023;56(5). doi:10.1111/cpr.13453
BibTeX
@article{Wang2023,
author = {Wang, Heran and Liu, Xin and Gu, Qi and Zheng, Xiongfei},
title = {Vascularized organ bioprinting: From strategy to paradigm},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {5},
doi = {10.1111/cpr.13453}
}
EUVIMED